Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Letter From The Editor

Letter from the Editor #703:

This week there was a change in guidelines concerning the use of cholesterol lowering medications. New guidelines from the American College of Cardiology...


Editor's Note, DCMS #162: Cystic Fibrosis and Diabetes

There are a lot of diseases caused by recessive traits that can be devastating to our patients with diabetes and even a few that can lead to diabetes. None of these are as deadly and well known as Cystic Fibrosis. This week our intern Afshaun...


Letter from the Editor, #702

For the last year we have had a generic version of the alpha glucosidase inhibitor, Acarbose. Many of you would never prescribe this medication because of the possible side effects of gas and gastric discomfort. In addition there did not appear to...



Special Edition: Type 2 Diabetes, Issue #1

Recently, a doctor who I used to do diabetes classes for called me. We had stopped the classes because of a lack of funding and he wanted to start them again. Part of his reason was to help his patients but he also knew that he was now being graded...


Special Insulin Edition #3: Insulin Therapy in Older Adults

I have spent the past couple of weeks preparing a CE webinar for the American Association of Nurse Assessment Coordination. This organization represents long-term care professionals who provide quality care for nursing home residents across the...


Editor's Note, DCMS #161

Over the past few years there has been a decrease in the ability of clinicians to diagnose and treat patients. According to a study in The Lancet, this decrease in diagnostic ability can be partly blamed on the increased use of smartphones...


Letter from the Editor #701

Last week I shared some information on saturated fat in my Letter from the Editor from the BMJ. Many of...


Editor's Note, DCMS #160

For the past three weeks we have given you a powerpoint presentation on changes in provider care, especially ACOs and PCHMs. During this time we have been discussing the way that these care models are being built and the goals they are striving...


Letter from the Editor #700:

Week after week it seems like old myths about diabetes, lipidemia and hypertension are falling by the wayside. For years we focused on calories and sugar and never made an effort to limit carbohydrates. In fact it has only been in the past five...


SGLT2 Inhibitors Special Edition Issue 7

It has taken a while but the use of the SGLT-2 Inhibitors appear to be catching on. My pharmacist colleagues have been telling me that more clinicians are writing for Invokana and patients are coming in for refills. It seems that some of the early...


Editor's Note, DCMS #159

This past Saturday I was working with 11 patients in an interactive education class at a progressive doctor's office in Palmetto, Florida. This office takes a very unique approach to diabetes and provides every patient who has an A1c of 5.7 or...


Letter from the Editor #699:

When you look up alpha-1 antitrypsin you find out that it is a protease inhibitor belonging to the serpin superfamily, and a deficiency leads to a condition in which the body does not make enough of a protein that protects the lungs and liver from...


Special Edition on Insulin, Issue #2

While we were preparing this endocrinologist-only special edition I realized that I had an opportunity to speak to the insulin experts. I am often called upon to speak to primary care physicians about early insulin use in type 2 patients and...


Editor's Note, DCMS #158

Did you know that clinicians who work for PCMH's actually get paid more money from state Medicaid and other programs than their colleagues who practice medicine "the old-fashioned way"? Payers are realizing that this care model gives...


Letter from the Editor, #698

This week we have an article on how gastric bypass and other laparoscopic procedures can cause remission in diabetes and improve cardiovascular...


Editor's Note, DCMS #157

Have you ever heard of the three letters, VBP? They stand for Value-based Purchasing and represent the latest tool to get high-quality, patient-centered, efficient, affordable healthcare. Our Homerun Slides this week cover


Letter from the Editor #697

This week we have some interesting news about medications for obesity and their effects on diabetes. Our first article looks at the...


Editor's Note, DCMS #156:

By the time that you read this newsletter we will either be in a funding gridlock or not, but regardless the Affordable Care Act will have started. A lot of attention has been on government programs but private health insurance is also affected by...


Letter from the Editor #696:

Friday I was in Dallas to talk to care and case managers from Blue Cross of Texas. The topic was Hospital Readmissions and the impact on the coordination of care continuum. The focus of the presentation was how to keep patients from returning to...


Editor's Note, DCMS #155:

Last weekend, I spent some time with our president, Andrew Young, in Manhattan Beach. I got in some good quality time on the bike while Andrew was surfing in what I would swear was freezing water. Andrew has very well-controlled diabetes and to do...


Letter from the Editor #695: Three Things Your Patients Can Do First Thing in the Morning

Over the years as an educator I have tried to find every advantage for my patients who have diabetes. For some reason many of my medical colleagues feel that if you tell a patient to do things the right way they will do it. Logic says that this...


Editor's Note - Tools for Initiating Insulin: Special Edition

For those of us who are old enough to remember the first Star Trek, or for the rest of you who only know the original series from Nick at Nite reruns, Captain James Kirk would start the show in his rich deep voice by saying "Space:...


Editor's Note, SGLT2-Inhibitor Special Issue #6

Over the past few months we have brought you the latest information on SGLT2 Inhibitors, examining this new class of drugs from every angle including how they work, prescription insurance coverage, and both clinician and patient experience with...


Editor's Note, DCMS #154: Affordable Care Act Slides Series

As we move closer to the implementation of the Affordable Care Act, there are still many unanswered questions as to how things will work, challenges from all sides of the political spectrum and healthcare industry, and a lot of misinformation...


Letter from the Editor, #694: Why Some Obese Patients Don't Get Diabetes

We have seen numerous studies demonstrating the value of resistance exercise for diabetes patients but often we only think of weights and machines and those methods rule out a lot of our patients. This week, Dr. Sheri Colberg brings us


Editor's Note, DCMS #153: How Red Food Dye in a Saline Solution Can Save Lives

Years ago, when a patient was referred to the pharmacy for instructions on how to start insulin, we would add red food coloring to the saline making it easier to see the exact amount of liquid in the test syringe. Over time, I have thought about...


Letter from the Editor #693:

Over the past month, I've done 20 hours of CE including a full day becoming certified at immunizations. In our area, every pharmacy, doctor's office and walk-in clinic offers flu shots, and as we move into the fall, the volume of flu shots...


Editor's Note: Advantages of Losing Weight

Every day we hear how weight loss is good for our patients with diabetes but when we speak to them we are talking in such ambiguous terms that they often don't see the value in losing weight. This is compounded by the fact that as we gain weight...


Letter from the Editor, #692: Team Novo Nordisk

Last week we had our reporter Jacqueline Middleton, and photographer Jay Maragon, at the final stage of the USA Pro Challenge. As you may know, this year Novo Nordisk has fielded a professional cycling team where all riders have type 1...


Editor's Note: Stopping Beta-cell Destruction and Team NovoNordisk

We know that type 1 diabetes results from T-cell–mediated destruction of beta-cells in the pancreas. So, to prevent type 1 diabetes from developing, we need to stop that destruction. In addition to our quest to eliminate type 1, we need to...


Letter from the Editor, #691: Health Exchanges Coming Soon

We are moving closer to the beginning of the Health Exchanges and it appears that many of the health plans will offer substantially smaller networks of hospitals and physicians than current health plans generally offer. Enrollees...


Editor's Note, SGLT2-I Issue #5

We've been bringing you these special newsletters about the SGLT2 inhibitors and hopefully they are helping you see how these new medications can be part of your patient treatment plan. For this edition, we have gone to


DCMS #150:

For the past eight years, both Steve Freed and I have been delivering CEU's on medical errors to pharmacists and nurses, and we are frequently asked what the biggest causes of errors are. After giving this considerable thought, I believe that...


Letter from the Editor #690: Can "Flipper" Help Save the Day for People with Diabetes?

There used to be a show on TV when I was a kid called "Flipper." Ranger Porter Ricks patrolled the waters around Coral Key Park with his two sons, Bud and Sandy, and their dolphin friend, "Flipper," solving crimes and spoiling...


Editor's Note, DCMS #149

This week we go back to the ADA Handbook for type 1 patients for our Clinical Text -- part 4 of our series on nutrition talks about nutrition including


Letter from the Editor, #689

Over the past months there have been a lot of articles about the idea that Alzheimer's disease may be another form of diabetes. In fact we have covered this information in previous issues of Diabetes In Control. While looking...


Editor's Note, DCMS #148

The most severe potential complication of DKA management is cerebral edema. It accounts for 60 – 90% of all DKA deaths. So if a newly diagnosed or young patient starts to slip into DKA, the proper treatment is very, very important. In...


Letter from the Editor, #688

Over and over we have new therapies for diabetes come to the market with lots of promise and hope. These new classes with great results in pre-marketing studies offer extra armament to fight the epidemic of diabetes yet they don’t get used...


Editor's Note, DCMS #147

I just finished a program in Danville, California, on hospital readmissions where I spoke to medical professionals about the high cost of readmissions and possible ways to avoid them. The program focused on using care and case managers to properly...


Letter from the Editor, #687: Sickle Cell and Diabetes

Last Monday, I was seeing patients at an endocrinologist's office and he asked us if we could see one more patient before we left. This patient was a 38 y/o African American female who had had diabetes for 3 years. Her last A1c was 6.2 but her...



Navigate through our listing of Letter From The Editor articles here.
First Previous Next Last

632 Total articles for Letter From The Editor


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here


Cast Your Vote
Do you believe that we could have a bionic pancreas by 2017?
CME/CE of the Week
Lawrence Lavery, DPM, MPH
ABPM, FACC, FCCWS

Category: Wound Care
Credits: .75


Advertisement


Search Articles On Diabetes In Control